Home › Funds › IQ EQ FUND MANAGEMENT (IRELAND) Ltd › BEAM

IQ EQ FUND MANAGEMENT (IRELAND) Ltd position in BEAM

BEAM THERAPEUTICS INC · Health Care

IQ EQ FUND MANAGEMENT (IRELAND) Ltd reported holding 507,140 shares of BEAM (BEAM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$12.4M, representing 0.76% of its reported portfolio and ranking #41 among its reported holdings. IQ EQ FUND MANAGEMENT (IRELAND) Ltd has disclosed BEAM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)507.14K sh
Reported value held$12.40M
Portfolio Weight0.76%
First reportedQ2 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How IQ EQ FUND MANAGEMENT (IRELAND) Ltd's BEAM position evolved

IQ EQ FUND MANAGEMENT (IRELAND) Ltd first disclosed a stake in BEAM in Q2 2024 at 9,303 shares (US$218K). The position peaked in Q2 2026 at 455,954 shares, worth US$15.6M. Across 10 filings, IQ EQ FUND MANAGEMENT (IRELAND) Ltd increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 507,140 shares valued at US$12.4M — an increase of 51,186 shares quarter over quarter.. Notable position changes include a 145% increase in Q4 2024 (shares fell 21% over the following quarter), a 103% increase in Q1 2025 (shares fell 12% over the following quarter), a 199% increase in Q2 2025 (shares rose 40% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 9.30K $217.97K New
Q3 2024 13.12K $321.39K Add
Q4 2024 32.20K $798.51K Add
Q1 2025 65.25K $1.27M Add
Q2 2025 195.29K $3.32M Add
Q3 2025 383.53K $9.31M Add
Q4 2025 533.56K $14.79M Add
Q1 2026 488.42K $11.64M Reduce
Q2 2026 455.95K $15.65M Reduce
Q3 2026 507.14K $12.40M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BEAM and 13F data

BEAM (BEAM THERAPEUTICS INC) is a Health Care company. 31 other funds we track also report a position in BEAM — the largest reported positions include Farallon Capital Management (US$351.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$351.3M), ARK Invest (US$288.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BEAM

All BEAM fund holders →

FAQ

How long has IQ EQ FUND MANAGEMENT (IRELAND) Ltd held BEAM?

IQ EQ FUND MANAGEMENT (IRELAND) Ltd has disclosed BEAM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is IQ EQ FUND MANAGEMENT (IRELAND) Ltd's current position in BEAM?

As of Q3 2026, IQ EQ FUND MANAGEMENT (IRELAND) Ltd holds 507.14K shares of BEAM (BEAM THERAPEUTICS INC), valued at $12.40M, representing 0.76% of its reported portfolio and ranking #41.

Has IQ EQ FUND MANAGEMENT (IRELAND) Ltd been buying or selling BEAM?

In the latest 13F filing (Q3 2026), IQ EQ FUND MANAGEMENT (IRELAND) Ltd increased its position in BEAM. The position peaked in Q2 2026 at 455.95K shares.

Which other funds hold BEAM?

Other major institutional holders of BEAM include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., ARK Invest, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.